Personal Cfo Solutions, LLC Selecta Biosciences Inc Transaction History

Personal Cfo Solutions, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.67 - $1.35 $2,680 - $5,400	-4,000 Reduced 7.29%	50,888 $35,000
Q3 2023 Nov 13, 2023	SELL	$1.02 - $1.23 $30,600 - $36,900	-30,000 Reduced 35.34%	54,888 $58,000
Q4 2022 Feb 14, 2023	SELL	$0.96 - $1.6 $960 - $1,600	-1,000 Reduced 1.16%	84,888 $95,000
Q3 2022 Nov 01, 2022	BUY	$1.33 - $2.6 $19,950 - $39,000	15,000 Added 21.16%	85,888 $141,000
Q2 2022 Aug 05, 2022	SELL	$0.67 - $1.4 $2,680 - $5,600	-4,000 Reduced 5.34%	70,888 $93,000
Q1 2022 May 02, 2022	BUY	$1.23 - $3.31 $23,985 - $64,545	19,500 Added 35.21%	74,888 $92,000
Q4 2021 Feb 11, 2022	BUY	$2.89 - $4.43 $34,821 - $53,377	12,049 Added 27.8%	55,388 $181,000
Q3 2021 Nov 18, 2021	BUY	$3.36 - $4.62 $47,900 - $65,862	14,256 Added 49.02%	43,339 $180,000
Q2 2021 Jul 22, 2021	BUY	$2.82 - $5.01 $82,014 - $145,705	29,083 New	29,083 $122,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Personal Cfo Solutions, LLC with notifications on news.